01669nas a2200349   4500000000100000008004100001260001300042653001500055653001000070653001600080653002300096653001000119653002100129653001100150653002100161653001100182653001000193653001200203653000900215653001600224653004200240100001700282700001900299700001200318245005900330856005900389300000900448490000700457050003200464520080900496022001401305       1990                            d  c1990 Mar10aAdolescent10aAdult10aBCG Vaccine10aBacterial Vaccines10aChild10aChild, Preschool10aFemale10aHealth Education10aHumans10aIndia10aleprosy10aMale10aMiddle Aged10aRandomized Controlled Trials as Topic1 aKartikeyan S1 aChaturvedi R M1 aDeo M G00aThe sociocultural dimension in leprosy vaccine trials.  uhttp://leprev.ilsl.br/pdfs/1990/v61n1/pdf/v61n1a06.pdf  a50-90 v61  aInfolep Library - available3 a<p>This paper briefly describes organizational, operational, and sociocultural aspects of the phase-III clinical trials of the ICRC anti-leprosy vaccine in Maharashtra, India. Our experience is that vaccine trials can be launched quickly and more cost effectively by using the services of health personnel from the existing public health infrastructure. That is why the trials could be launched in just 4 months after receiving the financial grant from the Indian Council of Medical Research, New Delhi (India). At the community level, a person-to-person approach in Health Education scores over audio-visual aids and the mass media. The compliance in target groups is increased when preventive programmes are backed-up by curative services and when their privacy and daily routine are not disturbed.</p>  a0305-7518